Breaking News, Financial News

Financial Report: BASi

Revenues up 2% driven by preclinical and bioanalytical services

BASi
 
3Q Revenues: $6.2 million (+2%)

3Q Earnings: $1.5 million (earnings were $215,000 3Q14)

YTD Revenues: $17.7 million (-2%)

YTD Earnings: $1.8 million (loss of $666,000 YTD14)

Comments: Service revenue for the quarter increased 5% to $5.0 million driven by Preclinical service and Bioanalytical analysis revenues partially offset by lower other lab services revenue. Product revenue decreased 10% to $1.1 million due to lower Analytical instrument sales.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters